{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T17:32:30Z","timestamp":1768930350728,"version":"3.49.0"},"reference-count":95,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.mcna.2021.05.015","type":"journal-article","created":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T12:13:00Z","timestamp":1631189580000},"page":"1081-1098","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["What to Do with Incidentally Discovered Pituitary Abnormalities?"],"prefix":"10.1016","volume":"105","author":[{"given":"Fabienne","family":"Langlois","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Fleseriu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mcna.2021.05.015_bib1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.beem.2011.06.004","article-title":"Thyroid incidentaloma","volume":"26","author":"Jin","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.mcna.2021.05.015_bib2","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.mcna.2021.05.015_bib3","first-page":"205","article-title":"Subclinical adenoma of the pituitary gland","volume":"12","author":"Costello","year":"1936","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.mcna.2021.05.015_bib4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ecl.2007.10.011","article-title":"Nonfunctioning pituitary tumors and pituitary incidentalomas","volume":"37","author":"Molitch","year":"2008","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"10","key":"10.1016\/j.mcna.2021.05.015_bib5","doi-asserted-by":"crossref","first-page":"817","DOI":"10.7326\/0003-4819-120-10-199405150-00001","article-title":"Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population","volume":"120","author":"Hall","year":"1994","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.mcna.2021.05.015_bib6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1148\/radiology.144.1.7089241","article-title":"Regions of low density in the contrast-enhanced pituitary gland: normal and pathologic processes","volume":"144","author":"Chambers","year":"1982","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.mcna.2021.05.015_bib7","first-page":"675","article-title":"Pituitary gland MR: a comparative study of healthy volunteers and patients with microadenomas","volume":"15","author":"Chong","year":"1994","journal-title":"AJNR Am J Neuroradiol"},{"issue":"4","key":"10.1016\/j.mcna.2021.05.015_bib8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0009-9260(84)80094-X","article-title":"Computed tomography of sellar and parasellar lesions","volume":"35","author":"Carr","year":"1984","journal-title":"Clin Radiol"},{"issue":"1","key":"10.1016\/j.mcna.2021.05.015_bib9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/jama.282.1.36","article-title":"Incidental findings on brain magnetic resonance imaging from 1000 asymptomatic volunteers","volume":"282","author":"Katzman","year":"1999","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.mcna.2021.05.015_bib10","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1210\/jc.2010-1048","article-title":"Pituitary incidentaloma: an endocrine society clinical practice guideline","volume":"96","author":"Freda","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.mcna.2021.05.015_bib11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1530\/eje.0.1490123","article-title":"A\u00a0survey of pituitary incidentaloma in Japan","volume":"149","author":"Sanno","year":"2003","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.mcna.2021.05.015_bib12","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1530\/EC-18-0065","article-title":"A\u00a0comparative, population-based analysis of pituitary incidentalomas vs clinically manifesting sellar masses","volume":"7","author":"Vaninetti","year":"2018","journal-title":"Endocr Connect"},{"issue":"1","key":"10.1016\/j.mcna.2021.05.015_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-16-0041","article-title":"Analysis and natural history of pituitary incidentalomas","volume":"175","author":"Imran","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.mcna.2021.05.015_bib14","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1590\/2359-3997000000195","article-title":"Incidence and prevalence of clinically relevant pituitary adenomas: retrospective cohort study in a Health Management Organization in Buenos Aires, Argentina","volume":"60","author":"Day","year":"2016","journal-title":"Arch Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.mcna.2021.05.015_bib15","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1530\/EJE-15-0189","article-title":"The epidemiology of pituitary adenomas in Iceland, 1955-2012: a nationwide population-based study","volume":"173","author":"Agustsson","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.mcna.2021.05.015_bib16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.5144\/0256-4947.2020.105","article-title":"Prevalence and characteristics of sellar masses in the city of Al Ain, United Arab Emirates: 2010 to 2016","volume":"40","author":"Aldahmani","year":"2020","journal-title":"Ann Saudi Med"},{"issue":"2","key":"10.1016\/j.mcna.2021.05.015_bib17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1017\/cjn.2015.301","article-title":"Sellar masses: an epidemiological study","volume":"43","author":"Al-Dahmani","year":"2016","journal-title":"Can J Neurol Sci"},{"issue":"12","key":"10.1016\/j.mcna.2021.05.015_bib18","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1210\/jc.2006-1668","article-title":"High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium","volume":"91","author":"Daly","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.mcna.2021.05.015_bib19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2265.2009.03667.x","article-title":"Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK)","volume":"72","author":"Fernandez","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.mcna.2021.05.015_bib20","series-title":"Video atlas of neurosirgery: contemporary tumors","first-page":"221","article-title":"Parasellar tumors","author":"Jackson","year":"2017"},{"key":"10.1016\/j.mcna.2021.05.015_bib21","series-title":"Netter's essential physiology","first-page":"314","article-title":"General principles of endocrinology and pituitary and hypothalamic hormones","author":"Mulroney","year":"2016"},{"issue":"4","key":"10.1016\/j.mcna.2021.05.015_bib22","doi-asserted-by":"crossref","first-page":"bvaa021","DOI":"10.1210\/jendso\/bvaa021","article-title":"Presenting features in 269 patients with clinically nonfunctioning pituitary adenomas enrolled in a prospective study","volume":"4","author":"Freda","year":"2020","journal-title":"J\u00a0Endocr Soc"},{"issue":"6","key":"10.1016\/j.mcna.2021.05.015_bib23","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1210\/jc.2011-0168","article-title":"Pituitary magnetic resonance imaging for sellar and parasellar masses: ten-year experience in 2598 patients","volume":"96","author":"Famini","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.mcna.2021.05.015_bib24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.rcl.2016.09.002","article-title":"Imaging of the sella and parasellar region","volume":"55","author":"Go","year":"2017","journal-title":"Radiol Clin North Am"},{"issue":"4","key":"10.1016\/j.mcna.2021.05.015_bib25","doi-asserted-by":"crossref","first-page":"R171","DOI":"10.1530\/EJE-15-1272","article-title":"Management of endocrine disease: pituitary \u2018incidentaloma\u2019: neuroradiological assessment and differential diagnosis","volume":"175","author":"Vasilev","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"10.1016\/j.mcna.2021.05.015_bib26","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.jacr.2018.03.037","article-title":"Management of incidental pituitary findings on CT, MRI, and (18)F-Fluorodeoxyglucose PET: a white paper of the ACR Incidental Findings Committee","volume":"15","author":"Hoang","year":"2018","journal-title":"J\u00a0Am Coll Radiol"},{"issue":"7","key":"10.1016\/j.mcna.2021.05.015_bib27","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1210\/jcem.86.7.7649","article-title":"Normal pituitary hypertrophy as a frequent cause of pituitary incidentaloma: a follow-up study","volume":"86","author":"Chanson","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.mcna.2021.05.015_bib28","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s11102-019-00940-4","article-title":"Pituitary incidentalomas in paediatric age are different from those described in adulthood","volume":"22","author":"Souteiro","year":"2019","journal-title":"Pituitary"},{"issue":"3","key":"10.1016\/j.mcna.2021.05.015_bib29","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s12022-017-9498-z","article-title":"Overview of the 2017 WHO classification of pituitary tumors","volume":"28","author":"Mete","year":"2017","journal-title":"Endocr Pathol"},{"issue":"2","key":"10.1016\/j.mcna.2021.05.015_bib30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11102-017-0855-1","article-title":"Histopathological classification of non-functioning pituitary neuroendocrine tumors","volume":"21","author":"Manojlovic-Gacic","year":"2018","journal-title":"Pituitary"},{"issue":"10","key":"10.1016\/j.mcna.2021.05.015_bib31","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1056\/NEJMra1810772","article-title":"Pituitary-tumor endocrinopathies","volume":"382","author":"Melmed","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.mcna.2021.05.015_bib32","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ecl.2020.04.002","article-title":"The epidemiology of pituitary adenomas","volume":"49","author":"Daly","year":"2020","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"2","key":"10.1016\/j.mcna.2021.05.015_bib33","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1742-1241.2010.02537.x","article-title":"Pituitary incidentalomas: a single-centre experience","volume":"65","author":"Anagnostis","year":"2011","journal-title":"Int J Clin Pract"},{"issue":"6","key":"10.1016\/j.mcna.2021.05.015_bib34","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s11102-015-0652-7","article-title":"Pituitary incidentalomas: analysis of a neuroradiological cohort","volume":"18","author":"Esteves","year":"2015","journal-title":"Pituitary"},{"issue":"2","key":"10.1016\/j.mcna.2021.05.015_bib35","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s11102-017-0858-y","article-title":"Silent somatotroph pituitary adenomas: an update","volume":"21","author":"Langlois","year":"2018","journal-title":"Pituitary"},{"issue":"2","key":"10.1016\/j.mcna.2021.05.015_bib36","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11102-018-0864-8","article-title":"Silent corticotroph adenomas","volume":"21","author":"Ben-Shlomo","year":"2018","journal-title":"Pituitary"},{"issue":"10","key":"10.1016\/j.mcna.2021.05.015_bib37","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1210\/jc.2015-2604","article-title":"A\u00a0case for conservative management: characterizing the natural history of radiographically diagnosed rathke cleft cysts","volume":"100","author":"Culver","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.mcna.2021.05.015_bib38","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s12020-018-1784-0","article-title":"High prevalence of adrenal insufficiency at diagnosis and headache recovery in surgically resected Rathke's cleft cysts-a large retrospective single center study","volume":"63","author":"Langlois","year":"2019","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.mcna.2021.05.015_bib39","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41572-019-0125-9","article-title":"Craniopharyngioma","volume":"5","author":"M\u00fcller","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"10.1016\/j.mcna.2021.05.015_bib40","doi-asserted-by":"crossref","first-page":"R275","DOI":"10.1530\/EJE-17-0505","article-title":"Diagnosis of endocrine disease: primary empty sella: a comprehensive review","volume":"177","author":"Chiloiro","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.mcna.2021.05.015_bib41","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/archinte.1995.00430020067008","article-title":"The natural history of the pituitary incidentaloma","volume":"155","author":"Donovan","year":"1995","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.mcna.2021.05.015_bib42","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1365-2265.2007.02990.x","article-title":"What is the natural history of nonoperated nonfunctioning pituitary adenomas?","volume":"67","author":"Karavitaki","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.mcna.2021.05.015_bib43","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1365-2265.1999.00748.x","article-title":"Incidentally discovered pituitary lesions: high frequency of macroadenomas and hormone-secreting adenomas - results of a prospective study","volume":"51","author":"Feldkamp","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"20","key":"10.1016\/j.mcna.2021.05.015_bib44","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1001\/jama.1990.03440200076026","article-title":"The \u2018incidentaloma\u2019 of the pituitary gland. Is neurosurgery required?","volume":"263","author":"Reincke","year":"1990","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.mcna.2021.05.015_bib45","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1210\/jc.2016-2118","article-title":"Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline","volume":"101","author":"Fleseriu","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.mcna.2021.05.015_bib46","series-title":"Conn's current therapy","article-title":"Hypopituitarism","author":"Langlois","year":"2021"},{"key":"10.1016\/j.mcna.2021.05.015_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP.17.4.636","article-title":"American association of clinical endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly-2011 update","volume":"17","author":"Katznelson","year":"2011","journal-title":"Endocr Pract"},{"issue":"1","key":"10.1016\/j.mcna.2021.05.015_bib48","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s12020-018-1764-4","article-title":"Signs and symptoms of acromegaly at diagnosis: the physician's and the patient's perspectives in the ACRO-POLIS study","volume":"63","author":"Caron","year":"2019","journal-title":"Endocrine"},{"issue":"5","key":"10.1016\/j.mcna.2021.05.015_bib49","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.mcna.2021.05.015_bib50","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jc.2010-1692","article-title":"Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline","volume":"96","author":"Melmed","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.mcna.2021.05.015_bib51","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2174\/1871530317666170424102332","article-title":"Hyperprolactinemia induced by antipsychotics: from diagnosis to treatment approach","volume":"17","author":"Milano","year":"2017","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"1","key":"10.1016\/j.mcna.2021.05.015_bib52","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000499694","article-title":"Pitfalls in the diagnostic evaluation of hyperprolactinemia","volume":"109","author":"Vilar","year":"2019","journal-title":"Neuroendocrinology"},{"issue":"3","key":"10.1016\/j.mcna.2021.05.015_bib53","first-page":"161","article-title":"Macroprolactin; a frequent cause of misdiagnosed hyperprolactinemia in clinical practice","volume":"11","author":"Richa","year":"2010","journal-title":"J\u00a0Reprod Infertil"},{"issue":"9","key":"10.1016\/j.mcna.2021.05.015_bib54","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.mcna.2021.05.015_bib55","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11916-018-0710-8","article-title":"Clinical presentation and management of headache in pituitary tumors","volume":"22","author":"Suri","year":"2018","journal-title":"Curr Pain Headache Rep"},{"issue":"2","key":"10.1016\/j.mcna.2021.05.015_bib56","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s11910-010-0166-7","article-title":"The association of pituitary tumors and headache","volume":"11","author":"Levy","year":"2011","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"2","key":"10.1016\/j.mcna.2021.05.015_bib57","first-page":"354","article-title":"Significant headache improvement after transsphenoidal surgery in patients with small sellar lesions","volume":"110","author":"Fleseriu","year":"2009","journal-title":"J\u00a0Neurosurg"},{"issue":"4","key":"10.1016\/j.mcna.2021.05.015_bib58","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s11102-019-00962-y","article-title":"Rathke's cleft cysts: a 6-year experience of surgery vs. observation with comparative volumetric analysis","volume":"22","author":"Barkhoudarian","year":"2019","journal-title":"Pituitary"},{"issue":"10","key":"10.1016\/j.mcna.2021.05.015_bib59","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1111\/j.1526-4610.2006.00539.x","article-title":"Headaches associated with Rathke's cleft cyst","volume":"46","author":"Nishioka","year":"2006","journal-title":"Headache"},{"issue":"3","key":"10.1016\/j.mcna.2021.05.015_bib60","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11102-005-1757-1","article-title":"Retrospective multicentric study of pituitary incidentalomas","volume":"7","author":"Day","year":"2004","journal-title":"Pituitary"},{"issue":"15","key":"10.1016\/j.mcna.2021.05.015_bib61","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1212\/WNL.0b013e3181d90017","article-title":"Diagnostic accuracy of confrontation visual field tests","volume":"74","author":"Kerr","year":"2010","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.mcna.2021.05.015_bib62","doi-asserted-by":"crossref","first-page":"R185","DOI":"10.1530\/EJE-19-0349","article-title":"Management of endocrine disease: visual morbidity in patients with pituitary adenoma","volume":"181","author":"Lithgow","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"10.1016\/j.mcna.2021.05.015_bib63","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1210\/jc.2011-2031","article-title":"Clinical review: pituitary carcinoma: difficult diagnosis and treatment","volume":"96","author":"Heaney","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.mcna.2021.05.015_bib64","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1210\/jc.2010-1054","article-title":"Natural history of nonfunctioning pituitary adenomas and incidentalomas: a systematic review and metaanalysis","volume":"96","author":"Fern\u00e1ndez-Balsells","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.mcna.2021.05.015_bib65","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s11102-017-0856-0","article-title":"Management of nonfunctioning pituitary adenomas (NFAs): observation","volume":"21","author":"Huang","year":"2018","journal-title":"Pituitary"},{"issue":"6","key":"10.1016\/j.mcna.2021.05.015_bib66","first-page":"884","article-title":"Natural course of incidentally found nonfunctioning pituitary adenoma, with special reference to pituitary apoplexy during follow-up examination","volume":"104","author":"Arita","year":"2006","journal-title":"J\u00a0Neurosurg"},{"issue":"3","key":"10.1016\/j.mcna.2021.05.015_bib67","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1530\/EJE-07-0502","article-title":"Growth modelling of non-functioning pituitary adenomas in patients referred for surgery","volume":"158","author":"Honegger","year":"2008","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"10.1016\/j.mcna.2021.05.015_bib68","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nrendo.2011.54","article-title":"The postoperative monitoring of nonfunctioning pituitary adenomas","volume":"7","author":"Wass","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.mcna.2021.05.015_bib69","series-title":"Pituitary tumors: a comprehensive and interdisciplinary approach","article-title":"Pituitary magnetic resonance imaging use in teh posttreatment follow-up of secreting pituitary adenomas","author":"Hinojosa-Amaya","year":"2021"},{"issue":"13","key":"10.1016\/j.mcna.2021.05.015_bib70","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1055\/s-0034-1389925","article-title":"Lower prolactin levels during cabergoline treatment are associated to tumor shrinkage in prolactin secreting pituitary adenoma","volume":"46","author":"Lombardi","year":"2014","journal-title":"Horm Metab Res"},{"issue":"1","key":"10.1016\/j.mcna.2021.05.015_bib71","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11102-019-01001-6","article-title":"Magnetic resonance imaging in the management of prolactinomas; a review of the evidence","volume":"23","author":"Varlamov","year":"2020","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.mcna.2021.05.015_bib72","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11102-018-0924-0","article-title":"Physicians' awareness of gadolinium retention and MRI timing practices in the longitudinal management of pituitary tumors: a \u201cPituitary Society\u201d survey","volume":"22","author":"Nachtigall","year":"2019","journal-title":"Pituitary"},{"issue":"4","key":"10.1016\/j.mcna.2021.05.015_bib73","doi-asserted-by":"crossref","first-page":"E527","DOI":"10.1227\/NEU.0000000000001387","article-title":"Congress of neurological surgeons systematic review and evidence-based guideline for pretreatment endocrine evaluation of patients with nonfunctioning pituitary adenomas","volume":"79","author":"Fleseriu","year":"2016","journal-title":"Neurosurgery"},{"issue":"4","key":"10.1016\/j.mcna.2021.05.015_bib74","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s11102-019-00960-0","article-title":"Non-functioning pituitary adenomas: indications for pituitary surgery and post-surgical management","volume":"22","author":"Esposito","year":"2019","journal-title":"Pituitary"},{"key":"10.1016\/j.mcna.2021.05.015_bib75","article-title":"Surgical treatment of pituitary adenomas","author":"Jane","year":"2000"},{"issue":"5","key":"10.1016\/j.mcna.2021.05.015_bib76","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11102-017-0838-2","article-title":"Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): a pituitary society statement","volume":"20","author":"Casanueva","year":"2017","journal-title":"Pituitary"},{"issue":"6","key":"10.1016\/j.mcna.2021.05.015_bib77","first-page":"2247","article-title":"Macroprolactinoma shrinkage during cabergoline treatment is greater in naive patients than in patients pretreated with other dopamine agonists: a prospective study in 110 patients","volume":"85","author":"Colao","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.mcna.2021.05.015_bib78","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1210\/jcem-60-4-698","article-title":"Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study","volume":"60","author":"Molitch","year":"1985","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.mcna.2021.05.015_bib79","doi-asserted-by":"crossref","first-page":"C11","DOI":"10.1530\/EJE-20-0607","article-title":"Dopamine agonists and antipsychotics","volume":"183","author":"Molitch","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.mcna.2021.05.015_bib80","doi-asserted-by":"crossref","first-page":"185","DOI":"10.9740\/mhc.2016.07.185","article-title":"Management of antipsychotic-induced hyperprolactinemia","volume":"6","author":"Tewksbury","year":"2016","journal-title":"Ment Health Clin"},{"issue":"1","key":"10.1016\/j.mcna.2021.05.015_bib81","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1530\/EJE-18-0682","article-title":"Psychological effects of dopamine agonist treatment in patients with hyperprolactinemia and prolactin-secreting adenomas","volume":"180","author":"Ioachimescu","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.mcna.2021.05.015_bib82","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3389\/fendo.2018.00469","article-title":"Dopamine agonists for pituitary adenomas","volume":"9","author":"Cooper","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"16","key":"10.1016\/j.mcna.2021.05.015_bib83","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.2165\/11318510-000000000-00000","article-title":"Medical therapy of acromegaly: efficacy and safety of somatostatin analogues","volume":"69","author":"Feelders","year":"2009","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.mcna.2021.05.015_bib84","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3803\/EnM.2017.32.2.162","article-title":"Recent progress in the medical therapy of pituitary tumors","volume":"32","author":"Langlois","year":"2017","journal-title":"Endocrinol Metab (Seoul)"},{"key":"10.1016\/j.mcna.2021.05.015_bib85","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3389\/fendo.2018.00164","article-title":"Pituitary-directed therapies for Cushing's disease","volume":"9","author":"Langlois","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"10.1016\/j.mcna.2021.05.015_bib86","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s11102-016-0742-1","article-title":"Updates on the role of adrenal steroidogenesis inhibitors in Cushing's syndrome: a focus on novel therapies","volume":"19","author":"Fleseriu","year":"2016","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.mcna.2021.05.015_bib87","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1530\/EJE-18-0255","article-title":"Mortality in acromegaly decreased in the last decade: a systematic review and meta-analysis","volume":"179","author":"Bolfi","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.mcna.2021.05.015_bib88","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ejim.2011.10.013","article-title":"Mortality in Cushing's syndrome: a systematic review and meta-analysis","volume":"23","author":"Graversen","year":"2012","journal-title":"Eur J Intern Med"},{"issue":"2","key":"10.1016\/j.mcna.2021.05.015_bib89","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11102-018-0863-9","article-title":"Mortality in patients with non-functioning pituitary adenoma","volume":"21","author":"Tampourlou","year":"2018","journal-title":"Pituitary"},{"issue":"3\u20134","key":"10.1016\/j.mcna.2021.05.015_bib90","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/BF02112028","article-title":"Pituitary apoplexy: endocrine, surgical and oncological emergency. Incidence, clinical course and treatment with reference to 799 cases of pituitary adenomas","volume":"120","author":"Bonicki","year":"1993","journal-title":"Acta Neurochir (Wien)"},{"issue":"5","key":"10.1016\/j.mcna.2021.05.015_bib91","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1227\/00006123-199011000-00011","article-title":"Hemorrhagic pituitary adenomas: clinicopathological features and surgical treatment","volume":"27","author":"Fraioli","year":"1990","journal-title":"Neurosurgery"},{"issue":"1","key":"10.1016\/j.mcna.2021.05.015_bib92","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2265.2010.03913.x","article-title":"UK guidelines for the management of pituitary apoplexy","volume":"74","author":"Rajasekaran","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.mcna.2021.05.015_bib93","first-page":"160021","article-title":"Gonadotropin-releasing hormone agonist-induced pituitary apoplexy","volume":"2016","author":"Keane","year":"2016","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"3","key":"10.1016\/j.mcna.2021.05.015_bib94","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jocn.2014.08.015","article-title":"Pituitary apoplexy following gonadotropin-releasing hormone agonist administration with gonadotropin-secreting pituitary adenoma","volume":"22","author":"Sasagawa","year":"2015","journal-title":"J\u00a0Clin Neurosci"},{"issue":"5","key":"10.1016\/j.mcna.2021.05.015_bib95","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1001\/jama.2016.19699","article-title":"Diagnosis and treatment of pituitary adenomas: a review","volume":"317","author":"Molitch","year":"2017","journal-title":"JAMA"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712521000845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712521000845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T19:43:11Z","timestamp":1672342991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712521000845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":95,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0025712521000845"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2021.05.015","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What to Do with Incidentally Discovered Pituitary Abnormalities?","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2021.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2021 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}